Inventor · disambiguated record
Olivier Terrier
Also filed as: TERRIER OLIVIER
9 granted patents·2 pending applications·10 citations·filing 2008–2021
80Inventor score
Files withUNIV CLAUDE BERNARD LYON7ROSA CALATRAVA MANUEL MELCHIOR JEAN-PIERRE2LINA BRUNO1TERRIER OLIVIER1
Top patents by PatentIndex Score
11 records- 0181US11351180B2Antiviral compositions for treating the fluUNIV CLAUDE BERNARD LYON·Filed 2016·Granted Jun 7, 2022·3 cites·5 claims
- 0270US11504424B2Attenuated virus strain and use thereof as a vaccineUNIV CLAUDE BERNARD LYON·Filed 2019·Granted Nov 22, 2022·1 cites·10 claims
- 0369US9381238B2Method for improving the production of influenza viruses and vaccine seedsTERRIER OLIVIER·Filed 2011·Granted Jul 5, 2016·4 cites·17 claims
- 0463US11510896B2Antiviral compositions for the treatment of infections linked to coronavirusesUNIV CLAUDE BERNARD LYON·Filed 2017·Granted Nov 29, 2022·1 cites·8 claims
- 0557US12285433B2Diltiazem for use in the treatment of microbial infectionsUNIV CLAUDE BERNARD LYON·Filed 2019·Granted Apr 29, 2025·0 cites·6 claims
- 0657US8926988B2Mutant proteins of the F protein of PIV-5 and PIV-2ROSA CALATRAVA MANUEL MELCHIOR JEAN-PIERRE·Filed 2009·Granted Jan 6, 2015·1 cites·30 claims
- 0755US12440498B2Combination of diltiazem and viral polymerase inhibitorsUNIV CLAUDE BERNARD LYON·Filed 2021·Granted Oct 14, 2025·0 cites·25 claims
- 0846US2022054618A1Production of viral vaccines on an avian cell lineUNIV CLAUDE BERNARD LYON·Filed 2019·Application pending·0 cites
- 0946US2023210866A1Composition comprising diltiazem for treating a viral infection caused by sars-cov-2 virusesUNIV CLAUDE BERNARD LYON·Filed 2021·Application pending·0 cites
- 1040US8927701B2HPIV-2 variants and their medical applicationsLINA BRUNO·Filed 2008·Granted Jan 6, 2015·0 cites·18 claims
- 1139US8906386B2Mutant proteins of the F protein of PIV-5 and PIV-2ROSA CALATRAVA MANUEL MELCHIOR JEAN-PIERRE·Filed 2009·Granted Dec 9, 2014·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Olivier Terrier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →